- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic Parameters of HIV‐1 Protease Inhibitors
Authors
Keywords
-
Journal
ChemMedChem
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-05-11
DOI
10.1002/cmdc.202000101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Choosing appropriate pharmacotherapy for drug-resistant HIV
- (2019) Amedeo Capetti et al. EXPERT OPINION ON PHARMACOTHERAPY
- pM to µM – Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance
- (2019) Mina Henes et al. ACS Chemical Biology
- Structural studies of antiviral inhibitor with HIV-1 protease bearing drug resistant substitutions of V32I, I47V and V82I
- (2019) Shrikant Pawar et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges
- (2019) Chandrashekhar Voshavar CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Performance of Bio-Rad HIV-1/2 Confirmatory Assay in HIV-1, HIV-2 and HIV-1/2 dually reactive patients - comparison with INNO-LIA and immunocomb discriminatory assays
- (2019) Jacob Lindman et al. JOURNAL OF VIROLOGICAL METHODS
- Insulin Resistance in HIV-Patients: Causes and Consequences
- (2018) Marcelo N. Pedro et al. Frontiers in Endocrinology
- HIV and its relationship to insulin resistance and lipid abnormalities
- (2017) Lemuel R. Non et al. Translational Research
- Random lopinavir concentrations predict resistance on lopinavir-based antiretroviral therapy
- (2016) Richard Court et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Improved adipose tissue function with initiation of protease inhibitor-only ART
- (2016) Robert T. Maughan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK
- (2016) Kate El Bouzidi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Defective Hydrophobic Sliding Mechanism and Active Site Expansion in HIV-1 Protease Drug Resistant Variant Gly48Thr/Leu89Met: Mechanisms for the Loss of Saquinavir Binding Potency
- (2015) Nathan E. Goldfarb et al. BIOCHEMISTRY
- A Comparative Insight into Amprenavir Resistance of Mutations V32I, G48V, I50V, I54V, and I84V in HIV-1 Protease Based on Thermodynamic Integration and MM-PBSA Methods
- (2015) Jianzhong Chen et al. Journal of Chemical Information and Modeling
- Darunavir Cmin and ritonavir-boosted darunavir monotherapy outcome in HIV-infected patients
- (2014) Alicia Gutierrez-Valencia et al. ANTIVIRAL THERAPY
- Drug Resistance Conferred by Mutations Outside the Active Site through Alterations in the Dynamic and Structural Ensemble of HIV-1 Protease
- (2014) Debra A. Ragland et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The High Cost of Fidelity
- (2013) Sarah B. Lloyd et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations
- (2013) Marianne Kraus et al. LEUKEMIA RESEARCH
- Pharmacokinetics, Safety and Antiviral Activity of Fosamprenavir/Ritonavir-containing Regimens in HIV-infected Children Aged 4 Weeks to 2 Years—48-week Study Data
- (2013) Mark Cotton et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- Mutations in HIV-1gagandpolCompensate for the Loss of Viral Fitness Caused by a Highly Mutated Protease
- (2012) Milan Kožíšek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adherence to Antiretroviral Treatment and Correlation with Risk of Hospitalization among Commercially Insured HIV Patients in the United States
- (2012) Paul E. Sax et al. PLoS One
- Should We Treat Acute HIV Infection?
- (2012) Meagan O’Brien et al. Current HIV/AIDS Reports
- The L76V Drug Resistance Mutation Decreases the Dimer Stability and Rate of Autoprocessing of HIV-1 Protease by Reducing Internal Hydrophobic Contacts
- (2011) John M. Louis et al. BIOCHEMISTRY
- A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes
- (2011) Kathleen M Doherty et al. BMC BIOINFORMATICS
- Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach? [Review article]
- (2011) A. Loeliger et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Antiretroviral Drug Interactions: Overview of Interactions Involving New and Investigational Agents and the Role of Therapeutic Drug Monitoring for Management
- (2011) R. Chris Rathbun et al. Pharmaceutics
- HIV Infection–Related Tuberculosis: Clinical Manifestations and Treatment
- (2010) Timothy R. Sterling et al. CLINICAL INFECTIOUS DISEASES
- Recent advances in antiretroviral drugs
- (2010) Raktim Kumar Ghosh et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pharmacokinetic Characterization of Three Doses of Tipranavir Boosted with Ritonavir on Highly Active Antiretroviral Therapy in Treatment-Experienced HIV-1 Patients
- (2010) Frank D. Goebel et al. HIV CLINICAL TRIALS
- Development and validation of discriminating method of dissolution for fosamprenavir tablets based on in vivo data
- (2010) Rochele C. Rossi et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Antiretroviral therapy and management of HIV infection
- (2010) Paul A Volberding et al. LANCET
- Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents
- (2009) Katherine M Coyne et al. AIDS
- New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir
- (2009) Christine A Hughes et al. EXPERT OPINION ON PHARMACOTHERAPY
- Detection of the protease codon 35 amino acid insertion in sequences from treatment-naïve HIV-1 subtype C infected individuals in the Central Region of Portugal
- (2009) João Pereira-Vaz et al. JOURNAL OF CLINICAL VIROLOGY
- Protease Inhibitor Resistance Update: Where Are We Now?
- (2008) Rose Kim et al. AIDS PATIENT CARE AND STDS
- Second generation HIV protease inhibitors against resistant virus
- (2008) Zhijian Lu Expert Opinion on Drug Discovery
- HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer models
- (2008) Paul W Hruz Current Opinion in HIV and AIDS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started